Immunoprecise Invested Capital Average vs Average Equity Analysis

IPA
 Stock
  

USD 3.84  0.04  1.05%   

Immunoprecise Antibodies financial indicator trend analysis is infinitely more than just investigating Immunoprecise Antibodies recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Immunoprecise Antibodies is a good investment. Please check the relationship between Immunoprecise Antibodies Invested Capital Average and its Average Equity accounts. Please see Risk vs Return Analysis.

Invested Capital Average vs Average Equity

Invested Capital Average vs Average Equity Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Immunoprecise Antibodies Invested Capital Average account and Average Equity. At this time, the significance of the direction appears to have totally related.
The correlation between Immunoprecise Antibodies' Invested Capital Average and Average Equity is 1.0. Overlapping area represents the amount of variation of Invested Capital Average that can explain the historical movement of Average Equity in the same time period over historical financial statements of Immunoprecise Antibodies, assuming nothing else is changed. The correlation between historical values of Immunoprecise Antibodies' Invested Capital Average and Average Equity is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Invested Capital Average of Immunoprecise Antibodies are associated (or correlated) with its Average Equity. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Average Equity has no effect on the direction of Invested Capital Average i.e., Immunoprecise Antibodies' Invested Capital Average and Average Equity go up and down completely randomly.

Correlation Coefficient

1.0
Relationship DirectionPositive 
Relationship StrengthVery Strong

Invested Capital Average

Average invested capital value for the period used in the calculation of [ROIC]; and derived from [InvCap]. Invested capital is an input into the calculation of [ROIC]; and is calculated as: Total Debt plus Total Assets minus Goodwill and Intangible Assets minus Cash and Equivalents minus Current Liabilities. Please note this calculation method is subject to change.

Average Equity

Average equity value for the period used in calculation of Return on Average Equity; derived from Shareholders Equity.
Most indicators from Immunoprecise Antibodies fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Immunoprecise Antibodies current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Please see Risk vs Return Analysis.The current year Issuance Purchase of Equity Shares is expected to grow to about 54.8 M, whereas Selling General and Administrative Expense is forecasted to decline to about 8.7 M.
 2019 2020 2021 2022 (projected)
Interest Expense537 K517 K594.55 K596.14 K
Gross Profit8.03 M11.54 M13.27 M11.78 M

Immunoprecise Antibodies fundamental ratios Correlations

0.98-0.960.980.58-0.990.920.651.0-0.960.990.820.82-0.7-0.960.821.00.930.851.0-0.55
0.98-0.971.00.62-1.00.90.680.98-0.960.990.840.84-0.7-0.950.840.980.930.850.98-0.59
-0.96-0.97-0.97-0.70.96-0.91-0.73-0.950.97-0.99-0.9-0.90.680.92-0.89-0.98-0.94-0.89-0.960.68
0.981.0-0.970.6-1.00.890.650.98-0.950.990.820.82-0.72-0.960.820.980.920.840.98-0.56
0.580.62-0.70.6-0.60.840.990.55-0.780.640.940.940.04-0.380.940.660.830.920.6-1.0
-0.99-1.00.96-1.0-0.6-0.91-0.66-0.990.96-0.99-0.82-0.820.690.95-0.82-0.99-0.93-0.85-0.990.56
0.920.9-0.910.890.84-0.910.90.9-0.990.930.950.95-0.37-0.770.960.951.00.980.92-0.82
0.650.68-0.730.650.99-0.660.90.63-0.840.70.960.960.0-0.440.960.720.880.960.67-0.98
1.00.98-0.950.980.55-0.990.90.63-0.950.990.790.79-0.72-0.960.790.990.920.831.0-0.52
-0.96-0.960.97-0.95-0.780.96-0.99-0.84-0.95-0.97-0.94-0.940.520.86-0.94-0.98-0.99-0.96-0.970.76
0.990.99-0.990.990.64-0.990.930.70.99-0.970.860.86-0.69-0.950.861.00.950.870.99-0.61
0.820.84-0.90.820.94-0.820.950.960.79-0.940.861.0-0.29-0.661.00.870.960.990.82-0.93
0.820.84-0.90.820.94-0.820.950.960.79-0.940.861.0-0.29-0.661.00.870.960.990.82-0.93
-0.7-0.70.68-0.720.040.69-0.370.0-0.720.52-0.69-0.29-0.290.88-0.28-0.65-0.43-0.27-0.69-0.06
-0.96-0.950.92-0.96-0.380.95-0.77-0.44-0.960.86-0.95-0.66-0.660.88-0.66-0.93-0.8-0.68-0.950.35
0.820.84-0.890.820.94-0.820.960.960.79-0.940.861.01.0-0.28-0.660.870.960.990.83-0.93
1.00.98-0.980.980.66-0.990.950.720.99-0.981.00.870.87-0.65-0.930.870.960.891.0-0.63
0.930.93-0.940.920.83-0.931.00.880.92-0.990.950.960.96-0.43-0.80.960.960.980.94-0.81
0.850.85-0.890.840.92-0.850.980.960.83-0.960.870.990.99-0.27-0.680.990.890.980.86-0.9
1.00.98-0.960.980.6-0.990.920.671.0-0.970.990.820.82-0.69-0.950.831.00.940.86-0.57
-0.55-0.590.68-0.56-1.00.56-0.82-0.98-0.520.76-0.61-0.93-0.93-0.060.35-0.93-0.63-0.81-0.9-0.57
Click cells to compare fundamentals

Immunoprecise Antibodies Account Relationship Matchups

Immunoprecise Antibodies Investors Sentiment

The influence of Immunoprecise Antibodies' investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Immunoprecise. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock markets does not have a solid backing from leading economists and market statisticians.

Immunoprecise Antibodies Implied Volatility

    
  181.77  
Immunoprecise Antibodies' implied volatility exposes the market's sentiment of Immunoprecise Antibodies stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Immunoprecise Antibodies' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Immunoprecise Antibodies stock will not fluctuate a lot when Immunoprecise Antibodies' options are near their expiration.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Immunoprecise Antibodies in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Immunoprecise Antibodies' short interest history, or implied volatility extrapolated from Immunoprecise Antibodies options trading.

Current Sentiment - IPA

Immunoprecise Antibodies Investor Sentiment

Macroaxis portfolio users are indifferent in their judgment towards investing in Immunoprecise Antibodies. What is your judgment towards investing in Immunoprecise Antibodies? Are you bullish or bearish?
Bullish
Bearish
50% Bullish
50% Bearish

Becoming a Better Investor with Macroaxis

Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Immunoprecise Antibodies using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.

Build Optimal Portfolios

Align your risk with return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Please see Risk vs Return Analysis. Note that the Immunoprecise Antibodies information on this page should be used as a complementary analysis to other Immunoprecise Antibodies' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .

Complementary Tools for Immunoprecise Stock analysis

When running Immunoprecise Antibodies price analysis, check to measure Immunoprecise Antibodies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immunoprecise Antibodies is operating at the current time. Most of Immunoprecise Antibodies' value examination focuses on studying past and present price action to predict the probability of Immunoprecise Antibodies' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Immunoprecise Antibodies' price. Additionally, you may evaluate how the addition of Immunoprecise Antibodies to your portfolios can decrease your overall portfolio volatility.
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Go
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Go
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Go
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Shere Portfolio
Track or share privately all of your investments from the convenience of any device
Go
Is Immunoprecise Antibodies' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Immunoprecise Antibodies. If investors know Immunoprecise will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Immunoprecise Antibodies listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
90.4 M
Quarterly Revenue Growth YOY
0.066
Return On Assets
-0.19
Return On Equity
-0.43
The market value of Immunoprecise Antibodies is measured differently than its book value, which is the value of Immunoprecise that is recorded on the company's balance sheet. Investors also form their own opinion of Immunoprecise Antibodies' value that differs from its market value or its book value, called intrinsic value, which is Immunoprecise Antibodies' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Immunoprecise Antibodies' market value can be influenced by many factors that don't directly affect Immunoprecise Antibodies' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Immunoprecise Antibodies' value and its price as these two are different measures arrived at by different means. Investors typically determine Immunoprecise Antibodies value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Immunoprecise Antibodies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.